Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Megha P. Nambiar, N. Ashwanikumar, Anakuthil Anoop & A. R. Biju. (2023) Binding energy analysis and molecular dynamic simulation studies of the designed orally active, non-toxic GABARAP modulators. Journal of Biomolecular Structure and Dynamics 41:13, pages 6394-6412.
Read now
Read now
Romina Moavero, Laura Rosa Pisani, Francesco Pisani & Paolo Curatolo. (2018) Safety and tolerability profile of new antiepileptic drug treatment in children with epilepsy. Expert Opinion on Drug Safety 17:10, pages 1015-1028.
Read now
Read now
Michele A Faulkner. (2015) Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome. Therapeutics and Clinical Risk Management 11, pages 905-914.
Read now
Read now
Articles from other publishers (21)
Pim B. van der Meer, Linda DirvenMarta FioccoMaaike J. VosMathilde C.M. Kouwenhoven, Martin J. van den BentMartin J.B. TaphoornJohan A.F. Koekkoek. (2023) Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy. Neurology 100:14.
Crossref
Crossref
Tülay Kamaşak, Esra Serdaroğlu, Özlem Yılmaz, Betül Aydın Kılıç, Burçin G. Polat, Irmak Erdoğan, A.Derda Yücel Şen, Nalan Özen, Betül Diler Durgut, Nihal Yıldız, Pınar Özkan Kart, Beril Dilber, Elif Acar Arslan, Sevim Şahin, Yasemin Topçu, Pınar Gencpinar, H. Mine Serin, Semra A. Hız, Kürşat Bora Çarman, Nihal Olgaç Dündar, Çetin Okuyaz, Kürşad Aydın, Ayşe Serdaroğlu, Hasan Tekgül & Ali Cansu. (2022) The effectiveness and tolerability of clobazam in the pediatric population: Adjunctive therapy and monotherapy in a large-cohort multicenter study. Epilepsy Research 184, pages 106963.
Crossref
Crossref
Shengying Lou & Sunliang Cui. (2022) Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary
Mechanisms. Current Medicinal Chemistry 29:19, pages 3366-3391.
Crossref
Crossref
Parthasarathy Satishchandra, Chaturbhuj Rathore, Anirudha Apte, Abhishek Kumar, Amlan Mandal, Dushyant Chauhan, Jagadish Agadi, Jayanti Gurumukhani, K. Asokan, K. Venkateshwarlu, Lokesh Lingappa, Nagarjunakonda Venkata Sundaracharya, Sudhir K. Jha, Sangeeta Ravat, Sanjeev VK, Siddhartha Garg, Sudhir Vadilal Shah, Sundaram Alagesan, Sushil Razdan, Uma Padhy, Vinay Kumar Agarwal, Vinod Arora, Bindu Menon, Sujatha Shetty & Deepa Chodankar. (2022) Evaluation of one-year effectiveness of clobazam as an add-on therapy to anticonvulsant monotherapy in participants with epilepsy having uncontrolled seizure episodes: An Indian experience. Epilepsy & Behavior 130, pages 108671.
Crossref
Crossref
Farzad Zamani, Esmail Doustkhah & Ronald W. Brown. 2022. Benzodiazepine-Based Drug Discovery. Benzodiazepine-Based Drug Discovery
283
294
.
Arya Sathyan, Reshma Scaria, Pavithra Arunachalam, Mohanapriya Ramasamy, Dithu Thekkekkara & Shalini Sivadasan. (2020) Antiepileptic Drugs–Induced Enuresis in Children: An Overview. Journal of Pharmacy Technology 37:2, pages 114-119.
Crossref
Crossref
Marta Vázquez, Carlos García-Carnelli, Cecilia Maldonado & Pietro Fagiolino. 2021. Cannabinoids and Sleep. Cannabinoids and Sleep
27
42
.
Bhuvanachandra Pasupuleti, Vamshikrishna Gone, Ravali Baddam, Raj Kumar Venisetty & Om Prakash Prasad. (2020) Clinical Impact of Co-medication of Levetiracetam and Clobazam with Proton Pump Inhibitors: A Drug Interaction Study. Current Drug Metabolism 21:2, pages 126-131.
Crossref
Crossref
Sravya Gedela, Daniel A Freedman, Satyanarayana Gedela, Peter Glynn, Ann Salvator & Anup D. Patel. (2019) Safety and Efficacy of Supratherapeutic Doses of Clobazam. Journal of Child Neurology 34:12, pages 735-738.
Crossref
Crossref
Marius Pernea & Alastair G. Sutcliffe. (2016) Clobazam and Its Use in Epilepsy. Pediatric Reports 8:2, pages 6516.
Crossref
Crossref
Margrete L. Burns, Arton Baftiu, Mimi S. Opdal, Svein I. Johannessen & Cecilie Johannessen Landmark. (2016) Therapeutic Drug Monitoring of Clobazam and Its Metabolite—Impact of Age and Comedication on Pharmacokinetic Variability. Therapeutic Drug Monitoring 38:3, pages 350-357.
Crossref
Crossref
Gwendolyn A. McMillin & Matthew D. Krasowski. 2016. Clinical Challenges in Therapeutic Drug Monitoring. Clinical Challenges in Therapeutic Drug Monitoring
101
134
.
Angela C. Gauthier & Richard H. Mattson. (2015) Clobazam: A Safe, Efficacious, and Newly Rediscovered Therapeutic for Epilepsy. CNS Neuroscience & Therapeutics 21:7, pages 543-548.
Crossref
Crossref
Sheri Cotterman-Hart. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors
171
193
.
Magdalena Florek-Luszczki, Miroslaw Zagaja & Jarogniew J. Luszczki. (2014) Influence of WIN 55,212-2 on the anticonvulsant and acute neurotoxic potential of clobazam and lacosamide in the maximal electroshock-induced seizure model and chimney test in mice. Epilepsy Research 108:10, pages 1728-1733.
Crossref
Crossref
Matthew D. Krasowski & Gwendolyn A. McMillin. (2014) Advances in anti-epileptic drug testing. Clinica Chimica Acta 436, pages 224-236.
Crossref
Crossref
Junji Saruwatari, Naoki Ogusu, Masatsugu Shimomasuda, Hiroo Nakashima, Takayuki Seo, Koji Tanikawa, Yoshiyuki Tsuda, Miki Nishimura, Rie Nagata, Norio Yasui-Furukori, Sunao Kaneko, Takateru Ishitsu & Kazuko Nakagawa. (2014) Effects of CYP2C19 and P450 Oxidoreductase Polymorphisms on the Population Pharmacokinetics of Clobazam and N-Desmethylclobazam in Japanese Patients With Epilepsy. Therapeutic Drug Monitoring 36:3, pages 302-309.
Crossref
Crossref
Gabriela Purcarin & Yu-Tze Ng. (2014) Experience in the use of clobazam in the treatment of Lennox–Gastaut syndrome. Therapeutic Advances in Neurological Disorders 7:3, pages 169-176.
Crossref
Crossref
Monica E. Lemmon & Eric H. Kossoff. (2013) New Treatment Options for Lennox-Gastaut Syndrome. Current Treatment Options in Neurology 15:4, pages 519-528.
Crossref
Crossref
James W. Wheless & Stephanie J. Phelps. (2012) Clobazam. Journal of Child Neurology 28:2, pages 219-229.
Crossref
Crossref
Jose de Leon, Edoardo Spina & Francisco J. Diaz. (2013) Clobazam Therapeutic Drug Monitoring. Therapeutic Drug Monitoring 35:1, pages 30-47.
Crossref
Crossref